Evénements Archive - Page 2 of 5 - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes
Evénements Archive - Page 2 of 5 - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes
  • Our Company
    • Presentation
    • Management Team
    • Board of directors
    • Scientific Advisory Board
    • Contact
  • Products
    • Tedopi®
    • OSE-279
    • Lusvertikimab (OSE-127)
    • Pegrizeprument (FR104)
    • BI 770371
    • ABBV-230
    • CLEC-1
  • Research & Development
    • Scientific publications
  • Investors
    • Press Releases
    • Regulated information
    • Financial documents
    • General Shareholders’ meetings
  • Partnerships
    • Pharma partnerships
    • Clinical partnerships
    • Academic and public Partnerships
  • News
    • Agenda
    • Press Releases
  • Contact
en
  • fr

P
r
o
j
e
c
t
s
A
r
c
h
i
v
e
s

January 2024

Paris European “Midcap Event”©
January 2024

Spring European “Midcap Event”©
January 2024

Paris European “Small & Midcap Event”©
January 2024

European “Midcap Event”©
January 2024

JPM HEALTHCARE CONFERENCE
December 2023

INVEST SECURITIES BIOMED FORUM 2024
October 2023

HealthTech Innovation Days
September 2023

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 2023

Protein & Antibody Engineering Summit (PEGS) Europe Summit
September 2023

Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
  • Précédent
  • 1
  • 2
  • 3
  • 4
  • 5
  • Suivant

Head Office

22, boulevard Benoni Goulin
44200 Nantes – France

Tel : +33 (0)2 28 29 10 10

Email : contact@ose-immuno.com

Paris Office

10, place de Catalogne
75014 Paris – France

Tel : +33 (0)1 43 29 78 57

Fax : +33 (0)1 42 03 04 16

Our Company
Products
Investors
Agenda
Research & Development
Partnerships
Press Releases
Follow us
©2021 ose-immuno
Financial documents
Legal information and Personal data protection policy
Site internet créé par Adveris